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1850Objectives: To update the Australian System for Cardiac Operative Risk Evaluation (AusSCORE) model for
operative estimation of 30-day mortality risk after isolated coronary artery bypass grafting in the Australian
population.
Methods: Data were collected by the Australian and New Zealand Society of Cardiac and Thoracic Surgeons
registry from 2001 to 2011 in 25 hospitals. A total of 31,250 patients underwent isolated coronary artery bypass
grafting and the outcomewas 30-day mortality. A total of 2154 (6.9%) patients had 1 or multiple missing values.
Missing values were estimated assuming missing completely at random and logistic regression with a
generalized estimating equation was used to address within-hospital variance. Bootstrapping methods were
used to construct and validate the updated model (AusSCORE II). Also the model was validated on an
out-of-creation sample of 4700 patients who underwent bypass surgery in 2012.
Results: The average age of the patients was 65.6  12.9 years and 78.6% were male. Thirteen variables were
selected in the updated model. The bootstrap discrimination and calibration of the AusSCORE II was very good
(receiver operating characteristics [ROC], 82.0%; slope calibration, 0.987). The overall observed/AusSCORE II
predicted mortality was 1.63% compared with the original AusSCORE predicted mortality of 1.01%.
The validation of the AusSCORE II on the out-of-sample data also showed a high performance of the model
(ROC, 84.5%; Hosmer-Lemoshow P value, .7654).
Conclusions: The AusSCORE II model provides improved prediction of 30-day mortality and successfully
stratifies patient risk. The model will be useful to improve the preoperative consultation regarding risk
stratification in terms of 30-day mortality. (J Thorac Cardiovasc Surg 2014;148:1850-5)Supplemental material is available online.The Australian System for Cardiac Operative Risk
Evaluation (AusSCORE) is a 30-day mortality risk
prediction model, which was developed for predicting
30-day mortality after isolated coronary artery bypass
grafting (CABG) in the Australian population.1 The
AusSCORE model was published in 2009 and was
developed based on 7709 patients who underwent isolated
CABG from 2001 to 2007 in 6 public hospitals in the state
of Victoria, Australia. However, since 2007 more hospitalse Departments of Epidemiology and Preventive Medicine,a and Surgery,b
sh University, Melbourne, Victoria; Department of Cardiothoracic Surgery,c
sh Medical Centre, Clayton, Victoria; Department of Defense Canberra,
Australiad; and Cabrini Medical Centre,e Malvern, Victoria, Australia.
res: Authors have nothing to disclose with regard to commercial support.
d for publication July 23, 2013; revisions received Jan 29, 2014; accepted for
ation Feb 3, 2014; available ahead of print March 18, 2014.
for reprints: Baki Billah, PhD, Department of Epidemiology and Preventive
cine, Monash University, Melbourne, Victoria 3004, Australia (E-mail: baki.
@monash.edu).
23/$36.00
ht  2014 by The American Association for Thoracic Surgery
.doi.org/10.1016/j.jtcvs.2014.02.027
The Journal of Thoracic and Cardiovascular Suracross Australia now contribute to the Australian and New
Zealand Society of Cardiac and Thoracic Surgeons
(ANZSCTS) registry and between 2001 and 2011 the
database accumulated 53,681 cardiac surgery patients. Of
these, 31,250 underwent isolated CABG. For the data
from 2001 to 2011, the original AusSCORE model
maintained a moderate discrimination power under the
area of the receiver operating characteristics (ROC) curve
but its calibration was dropped. Thus, the model failed to
maintain and optimize its usefulness in contemporary
cardiac surgical practice, especially in Australia and
New Zealand.
In addition to reduced calibration performance of the
original AusSCORE, risk model development techniques
have evolved over the past few years resulting in
better methods for risk prediction. Model validation
improvements include bootstrapping methods that give
bias-corrected accuracy indexes of the model and evaluate
model specification.2 The original AusSCORE model was
developed only for complete cases and the model did not
address within-hospital variation.
Thus, the objectives of this study were to (1) update the
original AusSCORE with a larger dataset, (2) estimate
missing values, (3) address the within-hospital variation,
(4) develop and validate the model using bootstrap methodsgery c November 2014
Abbreviations and Acronyms
AIC ¼ Akaike Information Criteria
ANZSCTS ¼Australian and New Zealand Society
of Cardiac and Thoracic Surgeons
AusSCORE ¼ Australian System for Cardiac
Operative Risk Evaluation
CABG ¼ coronary artery bypass grafting
eGFR ¼ glomerular filtration rate
EuroSCORE ¼ European System for Cardiac
Operative Risk Evaluation
H-L ¼ Hosmer-Lemoshow
IV ¼ intravenous
MI ¼ myocardial infarction
NYHA ¼ New York Heart Association
RAMR ¼ risk adjusted mortality ratio
ROC ¼ receiver operating characteristics
STS ¼ Society of Thoracic Surgeons
Billah et al Acquired Cardiovascular Disease
A
C
Drather than split-sample methods,2 (5) evaluate model
specification, and (6) develop an online calculator for
30-day mortality risk prediction.METHODS
ANZSCTS Database
The ANZSCTS prospectively collects information on adult patients
undergoing cardiac surgery in Australia. Currently, 25 hospitals across
Australia and New Zealand are contributing data to the registry.
Participation in the data registry is voluntary in terms of hospitals but if
a hospital participates, the surgeons’ participation is compulsory. The
database prospectively collects 287 preoperative, intraoperative, and
postoperative variables. The ANZSCTS data were collected using
internationally standardized data definitions.1,3 The data collection and
its audit methods have been discussed previously.1,4 The variable
glomerular filtration rate had maximum missing values (2.58%)
followed by ejection fraction estimate (2.52%), urgency of procedures
(1.11%), and 30-day mortality (1.01%). The remaining variables had
less than 0.12% missing observations. The missing observations were
estimated using multiple imputation assuming they were missing
completely at random,12 The primary outcome variable for this study
was 30-day mortality. The 30-day mortality status was collected by the
hospital data managers by contacting patients, family members, or
medical practitioners by follow-up visits or via telephone as part of clinical
care.
Statistical Analysis
Stata version 11 (Stata Corporation, College Station, Tex) and R version
2.13.1 (The R Foundation for Statistical Computing) were used for data
analysis. Clinical assessment along with the c2 test and simple logistic
regression were used to identify potential preoperative risk factors for
30-day mortality. Statistically, a variable with P value of .25 or less was
considered to be a potential risk factor. A bootstrap sample of size n was
drawn from the original sample of the same size. The potential risk factors
were entered into the multiple logistic regression model and were applied
to the bootstrap samples to test the significance of the variables. A variable
with a P value of less than or equal to .05 was considered significant.
The process was repeated 1000 times and the percentage of times that
each variable appeared as significant in 1000 bootstraps was recorded.The Journal of Thoracic and CarDepending on the percentage of times the potential variables appeared as
significant, 4 plausible models were developed. The final model
was selected using Akaike Information Criteria (AIC),5 ROC, and
Hosmer-Lemoshow (H-L) P value of goodness of fit test. The first-order
interaction effect and multicollinearity between clinically relevant risk
factors were investigated. A generalized estimating equation was used to
account for potential within-hospital variation.13 The model was validated
using bootstrap methods, which provide unbiased estimates of the model’s
future performance (index-corrected ROC, calibration slope, and graph).2
The model was also validated for a validation sample. An online risk
calculator was developed to predict a patient’s preoperative risk of
30-day mortality.RESULTS
Patient Characteristics
Between 2001 and 2011, the ANZSCTS database
accumulated 53,681 patients who underwent cardiac
surgery and, of those, 57.6% (n ¼ 31,250) were isolated
CABG procedures. From the list of 37 main preoperative
variables, the 21 variables that were selected as potential
risk factors for 30-day mortality are shown in Table 1.
The patient demographics and odds ratio for these variables
along with the P value and 95% confidence interval are also
presented in Table 1.
Compared with the data from which the original
AusSCORE was derived (in brackets) patients were similar
in age (65.6 12.9 years [65.7 10.1 years]), 78.6% were
male (76.8%), and overall 30-day mortality was 1.63%
(1.74%). More patients were octogenarians (7.3%
[5.3%]), on dialysis (1.6% [1.3%]), and had hyper-
cholesterolemia (81.0% [17.9%]). The definition of
hypercholesterolemia has changed for the current data to
include anyone being treated for hypercholesterolemia;
most cardiac patients are on statins, whether or not they
are actually hyperlipidemic. However, fewer patients
had a severely impaired ejection fraction estimate (4.3%
[5.2%]), New York Heart Association (NYHA) class III
or IV (20% [26.3%]), and were classified clinically as
emergency or salvage (4.3% [4.6%]).Risk Model
One thousand bootstrap samples each of the size of the
original sample were drawn from the original data. The
21 variables that were selected as potential predictors
were entered into a multiple logistic regression model and
was run on each of the bootstrap samples. The percentage
of times each variable was selected as significant (P value
.05) was recorded. The following 4 potential models
were developed: model 1, variables selected in at least
90% of bootstrap samples (age, ejection fraction estimate,
previous cardiac surgery, urgency of procedures, estimated
glomerular filtration rate [eGFR], NYHA class, inotrope
administration, and myocardial infarction [MI]); model 2,
variables selected in at least in 80% of bootstrap
samples (all variables in model 1 and 3 additional variablesdiovascular Surgery c Volume 148, Number 5 1851
TABLE 1. Patient demographics and potential risk factors for 30-day
mortality after isolated coronary artery bypass grafting
Variable
Prevalence%
(N ¼ 31,250) OR
P
value
95%
CI
Died within 30 d (%) 1.63 — — —
Age, y mean  SD 65.6  12.9 — — —
Age (ref:<70 y): 61.4 — — —
70-79 y 31.3 2.3<.001 1.9-2.8
80 y 7.3 4.4<.001 3.4-5.6
Ejection fraction (ref:>45%): 80.0 — — —
Moderate (30%-45%) 15.7 2.7<.001 2.2-3.4
Severe (<30%) 4.3 9.1<.001 7.2-11.5
Peripheral vascular disease 12.2 2.2<.001 1.8-2.8
Diabetic (yes) 33.6 1.2 .020 1.0-1.5
eGFR (ref: 90 mL/min/1.73 m2) 39.1 — — —
Mild 60-89 mL/min/1.73 m2 36.3 2.0<.001
<.001
<.001
<.001
1.5-2.7
Moderate 30-59 mL/min/1.73 m2 21.1 4.7<.001 3.6-6.1
Severe<30 mL/min/1.73 m2 2.1 9.5<.001 6.4-14.1
Dialysis 1.6 6.6<.001 4.0-10.8
Cerebrovascular disease 10.9 1.6<.001 1.3-2.1
Respiratory disease 12.2 1.5<.001 1.2-1.9
Hypercholesterolemia 81.0 0.8 .017 0.6-1.0
Inotrope administration 1.6 14.2<.001 11.0-18.3
NYHA class (ref: I and II) 80.1 — — —
III 15.3 2.2<.001 1.8-2.7
IV 6.7 6.9<.001 5.5-8.7
Previous cardiac surgery 4.5 2.8<.001 2.1-3.7
Family history of CD 42.3 0.7 .003 0.6-0.9
Cardiogenic shock 1.7 15.2<.001 11.9-19.4
Gender (female) 21.4 1.9<.001 1.6-2.3
Urgency (ref: elective) 84.2 — — —
Urgent 11.4 1.4 .015 1.1-1.9
Emergency/salvage 4.3 9.2<.001 7.4-11.3
IV nitrate administration 7.4 4.9<.001 3.6-5.5
Anticoagulant medication 23.7 2.7<.001 2.3-3.3
BSA>1.73 m2 82.7 0.5<.001 0.4-0.6
Preoperative MI 54.0 2.6<.001 2.1-3.2
Hypertension 78.8 1.4 .006 1.1-1.8
Preoperative resuscitation<1 h 0.9 12.6<.001 9.1-17.5
OR, Odds ratio; CI, confidence interval; eGFR, estimated glomerular filtration rate;
NYHA, New York Heart Association; CD, cardiac disease; BSA, body surface area;
MI, myocardial infarction; IV, intravenous; SD, standard deviation. See Appendix
E1 for specific variable definition. See Appendix E2 for eGFR calculator.
TABLE 2. 30-day mortality risk prediction model: AusSCORE II
Variable OR P value 95% CI
Age (ref:<70 y) — — —
70-79 y 1.6 <.001 1.5-1.8
80 y 2.6 <.001 2.4-2.9
Ejection fraction (ref:>45%) — — —
Moderate (30%-45%) 1.7 <.001 1.5-1.9
Severe (<30%) 3.6 <.001 3.1-4.2
Previous cardiac surgery 2.3 <.001 1.9-2.8
eGFR (ref: 90 mL/min/1.73 m2) — — —
60-89 mL/min/1.73 m2 1.5 .003 1.2-2.0
30-59 mL/min/1.73 m2 2.0 <.001 1.7-2.4
<30 mL/min/1.73 m2 3.8 <.001 2.8-5.1
Dialysis 3.9 <.001 2.4-6.3
Urgency (Ref: elective) — — —
Urgent 1.1 .190 0.9-1.4
Emergency/salvage 2.6 <.001 2.1-3.1
NYHA class (ref: I and II) — — —
III 1.4 <.001 1.2-1.6
IV 1.8 <.001 1.5-2.1
Inotrope administration 2.1 <.001 1.8-2.6
Peripheral vascular disease 1.5 <.001 1.3-1.7
Previous MI 1.5 <.001 1.4-1.6
Anticoagulant medication 1.3 .019 1.0-1.6
Gender (female) 1.5 <.001 1.3-1.6
Cardiogenic shock 1.8 <.001 1.4-2.3
IV nitrates administration 1.5 <.001 1.2-1.8
OR, Odds ratio; CI, confidence interval; eGFR, estimated glomerular filtration rate;
NYHA, New York Heart Association; MI, myocardial infarction; IV, intravenous.
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gender]); model 3, variables selected in at least in 60% of
bootstrap samples (all variables in model 2 and 2 additional
variables [cardiogenic shock and intravenous (IV) nitrate
administration]); and model 4, all 21 variables in Table 1.
The ROC, H-L P value, and AIC for these models are
respectively as follows: model 1, 81.8%, 32.7%, and
3965; model 2, 82.2%, 32.4%, and 3943; model 3,
82.4%, 60.1%, and 3936; model 4, 82.3%, 45.0%, and
3588. The H-L P value does not necessarily increase with
increasing number of variables in the model. Model 31852 The Journal of Thoracic and Cardiovascular Surwith 13 variables was selected as the final model
(AusSCORE II) by comparing ROC, H-L P value, and
AIC between the 4 potential models. The variables in the
final model are age, gender, ejection fraction estimate,
previous cardiac surgery, urgency of procedures, eGFR,
NYHA class, inotrope administration, MI, peripheral
vascular disease, anticoagulant medication, cardiogenic
shock, and IV nitrate administration. There is no
multicollinearity or first-order interaction effect between
the risk factors in the model. Among the variables in the
final risk model, IV nitrate administration was selected in
the least number (66.5%) of bootstrap samples. No
variables were selected in between 30% and 65% of the
samples. Hence, variables that were significant in less
than 30% of the samples were excluded from the final
model despite some of them occurring often in patients
undergoing CABG.
The risk factors in the AusSCORE II model and their
corresponding odds ratio, 95% confidence interval, and
P value are presented in Table 2. The key drivers for
30-day mortality after CABG were age 80 years or more,
ejection fraction less than 30%, previous cardiac surgery,
eGFR less than 30 mL/min/1.73msq (excludes dialysis),
on dialysis, having an emergency or salvage procedure,
NYHA class IV, and inotrope administration. Women had
a higher risk than men.gery c November 2014
FIGURE 1. Comparison of risk adjustedmortality ratio (RAMR) between AusSCORE II and the original AusSCORE.NYHA, NewYork Heart Association;
eGFR, estimated glomerular filtration rate; AusSCORE, Australian System for Cardiac Operative Risk Evaluation.
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The overall prediction of 30-day mortality for
the AusSCORE II model compared with the original
AusSCORE model was as follows: AusSCORE
II/observed, 1.63%; original AusSCORE, 1.01%. The
overall risk adjusted mortality ratio (RAMR, observed/
expected) was 1.61 for the original AusSCORE. Thus, the
original AusSCORE model underestimated the mortality
risk and hence had reduced calibration for the current data.The Journal of Thoracic and CarThe optimally corrected ROC (82.0%) and slope
calibration (0.987) for AusSCORE II were very high,
demonstrating a successful logistic model. The bootstrap
calibration curve presented in Figure E1 also shows an
excellent calibration especially for low to high-risk
patients. When validated on the original data, the
discrimination of AusSCORE II was better than the original
AusSCORE (within brackets): ROC, 81.9% (78.28%).
AusSCORE II calibrated well (H-L P value .4232) but thediovascular Surgery c Volume 148, Number 5 1853
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calibration. The RAMR for some specific risk factors is
presented in Figure 1, again demonstrating good calibration
for the AusSCORE II model. The original AusSCORE
model, however, had a poorer calibration and strong
tendency to underestimate 30-day mortality.
When validated on the 2012 data, both models showed a
very good discrimination power, however the original
AusSCORE model had a poor calibration (AusSCORE II,
ROC 84.5%, H-L P value .7654; AusSCORE, ROC
84.3%, H-L P value .0019). Furthermore, the calibration
of the AusSCORE II model, when examined by comparing
mean observed and predicted mortalities for each decile of
the predicted values (Figure E2), demonstrates that in
general the model was well calibrated.
The discrimination power of the AusSCORE II was also
compared with that of the EuroSCORE II and the Society of
Thoracic Surgeons (STS) model and it was found that the
ROC of AusSCORE II (82%) was competitive with that
of the EuroSCORE II (80.95%) and STS (81.2%) models
when they were validated on their own data.Model Specification
The 1000 bootstraps for variable selection for
AusSCORE II was repeated 10 times to evaluate the model
specification (or variable uncertainty). The variation in the
percentage of times that each of the 21 potential variables
was selected in each of the 10 sets of 1000 bootstrapping
was insignificant and, hence, in each repeat the same set
of variables was selected in the AusSCORE II model
suggesting a stable model.Online Calculator and Case Study
An online calculator was developed to predict patient’s
30-day mortality and risk group. Consider a patient who
was female, 76 year old, classified as NYHA class III,
had eGFR 80 mL/min, and ejection fraction 40%. The
patient underwent isolated CABG on an elective basis.
Using the calculator, the patient’s 30-day mortality risk
was 1.53% (Figure E3).DISCUSSION
The original AusSCORE model was published in 2009
and was developed based on the Australian Society of
Cardiac and Thoracic Surgeons data collected from 6 public
hospitals between 2001 and 2007 in the state of
Victoria, Australia. Since the development of the original
AusSCORE model, the plan was to update the model after
the completion of 20,000 isolated CABGs. The database
currently includes data from 25 private and public hospitals
across Australia and now includes 53,681 patients, of whom
31,250 underwent isolated CABG. Thus, these data are now
more representative of the Australian population compared1854 The Journal of Thoracic and Cardiovascular Surwith the dataset used to derive the original AusSCORE
model.
Model specification, which greatly depends on the
uncertainty in the variables in the model, should be a
concern in any risk modeling.2 However, this has not been
addressed for risk modeling in the literature. The model
specification for AusSCORE II was evaluated using
multiple sets of bootstrapping. The results showed that the
uncertainty in the variable selection in the AusSCORE II
model was minimal, suggesting the model was specified
adequately.
The original AusSCORE and other risk models in the
literature, including EuroSCORE II and the STS model,
were developed based on the split-sample method. The
split-sample method affects a model’s predictive accuracy
and precision of the estimates of the accuracy. AusSCORE
II, however, was developed on an entire dataset and was
validated using the bootstrap method. The bootstrap method
uses the full dataset for model development and model
validation. This method provides the bias-corrected
discriminatory and calibration power of the model. The
bootstrap method gives slope calibration as opposed to the
H-L P value; the latter method has some inherent
limitations.6-8 Addressing within-hospital variation and
missing value estimation using multiple imputation was
another key addition to the AusSCORE II model.
In the original AusSCORE model, serum creatinine
(mg/dL) level was used as a measure of kidney dysfunction,
however eGFR was used in the AusSCORE II model. The
eGFR depends on the patient’s age, gender, weight, and
serum creatinine level (mg/dL) and is a better indicator of
kidney dysfunction.9 Also the category ‘‘urgent’’ for
‘‘urgency of procedures’’ was tightened whereby a patient
was classified as ‘‘urgent’’ if the surgery took place within
72 hours of catheterization.
In AusSCORE II, 13 variables were identified as the key
risk factors compared with 8 variables in the original
AusSCORE model.1 The new variables in the AusSCORE
II model were gender, previousMI, inotrope administration,
IV nitrate administration, anticoagulant medication, and
cardiogenic shock. This showed that the patient’s
preoperative risk has increased since the development of
the original AusSCORE model. However, the overall
30-day mortality has dropped perhaps because of
improvement in cardiac surgery techniques, early
intervention, and increased postoperative care. The variable
hypercholesterolemia was significant in the original
AusSCORE model but was not significant in the
AusSCORE II. This may be a reflection of the increased
use of statin medication across the population in the current
database. The diabetic status of a patient was significant in
the simple logistic regression, however was insignificant
when adjusted for other potential risk factors. This may
be because diabetic status is associated with peripheralgery c November 2014
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dysfunction. Being female was a risk factor in the
AusSCORE II model, which is supported by the
EuroSCORE II and STS models.6,7,10
Compared with the original AusSCORE, AusSCORE II
was a better predictor of 30-day mortality. The original
AusSCORE model maintained good discrimination but its
calibration was poorer for the current data. The original
AusSCORE model underpredicts mortality for this
population. This may be because the AusSCORE II model
is more representative of the population or because of
improvements in model development and validation
methods.2
The original EuroSCORE model did not accurately
predict outcomes in the Australian population.11 The
EuroSCORE II and STS models could not be validated
for the Australian cohort because of differences in data
definition between these registries. For example, the
variables extracardiac arteriopathy, chronic pulmonary
dysfunction, neurologic or musculoskeletal dysfunction,
critical, pulmonary artery systolic pressure, and thoracic
aorta in the EuroSCORE II model are not available in the
ANZSCTS registry. It would be ideal if consensus could
be reached regarding unique data definitions across
populations that would assist in model standardization
and benchmarking. A study is inevitable to address all
data definition differences between the major international
data registries. The discriminatory power of the AusSCORE
II model was found to be as good as or better than most of
the risk models in the literature, including the original
AusSCORE, EuroSCORE II, and STS models, when they
were applied to their own data.6,7,10
The online calculator was an important addition to the
Australian 30-day mortality risk prediction after isolated
CABG. This is the first attempt to evaluate a patient’s
preoperative risk of mortality online; which can be used
to calculate logistic (absolute) risk of 30-day mortality.Limitations
The conversion of continuous age to categorical is a
limitation of this study. However, the interpretation of riskThe Journal of Thoracic and Carassociated with categorical variables is easy to follow
by cardiologists, cardiac surgeons, and other medical
professionals in preference to continuous variables.
Furthermore, this type of model can easily be validated on
any external data, which makes the model user friendly.
CONCLUSIONS
AusSCORE II is the updated version of the original
AusSCORE model, which will help to improve
preoperative decision making, as well as risk stratification
and patient counseling.
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DAPPENDIX E1. DESCRIPTION OF KEY
VARIABLES
Estimated glomerular filtration rate (eGFR): estimates
how much blood passes through the tiny filters in
the kidneys, called glomeruli, each minute. Kidney
function is classified as normal (eGFR 90 mL/min/
1.73msq), mild (eGFR 60-89 mL/min/1.73msq),
moderate (eGFR 30-59 mL/min/1.73msq), severe
(eGFR 29 mL/min/1.73msq), and dialysis. The stages
normal to severe exclude dialysis.
Urgency of procedures: elective, the procedure could be
deferred without increased risk of compromised cardiac
outcome; urgent, the patient had the surgery within 72
hours of catheterization; emergency, unscheduled surgery
required in next available theatre on same day because of
refractory angina or cardiac compromise; salvage, the
patient is undergoing cardiopulmonary resuscitation en
route to the operating room, that is, before surgical
incision.
Cardiogenic shock: is the patient, at the time of
procedure, in a clinical state of hypoperfusion according
to either of the following criteria: (1) systolic blood
pressure 80 mm Hg and/or cardiac index 1.8 despite
maximal treatment; (2) IV inotropes and/or intra-aortic
balloon pump necessary to maintain systolic blood
pressure>80 mm Hg and/or cardiac index>1.8.
Nitrate administration: patient on IV nitrates on day of
surgery (on drug when entered operation).
Inotrope administration: any inotrope use to maintain
cardiac output for longer than 4 hours postoperatively
(includes dopamine at >300 mg/min). Note: routinely
administered milrinone does not count.
Anticoagulant medication: patient given warfarin/
heparin/low molecular weight heparinoid24 hours before
surgery.
Peripheral vascular disease: whether the patient has
peripheral vascular disease, as indicated by claudication
either with exertion or at rest; amputation for arterial
insufficiency; aorto-iliac occlusive disease reconstruction;
peripheral vascular bypass surgery, angioplasty, or stent;
documented abdominal aortic aneurysm, abdominal aortic
aneurysm repair, or stent; positive noninvasive testing
documented.1855.e1 The Journal of Thoracic and Cardiovascular SurAPPENDIX E2. CALCULATION OF EGFR
eGFR was calculated using the Cockroft-Gault formulae9
where the creatinine level was adjusted for the patient’s
age, weight, and gender:
eGFR ¼ ðweight ½kg3ð140age ½yearsÞÞ
3gender=ð723serum creatinine ½mg=dLÞ
where gender ¼ 1 for male and 0.85 for female.
Prediction Model
The following multivariable logistic regression model
was used for 30-day mortality risk prediction:
Mortality risk ¼ expðb0þ
P
bXþP bXÞ
1þexpðb0þ
P
bXþP bXÞ
where b0 is the baseline effect and
P
bX is the sum of b
coefficients for all risk factors (categorical) present in the
patient (X ¼ 1 if the risk factor is present and X ¼ 0 if
absent). For each continuous covariate, the b coefficient is
multiplied by the value of the covariate and then added up
for all covariates. This add up value is denoted byP
b*X* in this model. In the AusSCORE II model, there
is no continuous covariate, hence the term
P
b*X* was
dropped from the model.
Risk Prediction
The AusSCORE II model can be used to calculate the
logistic risk for 30-day mortality for each patient under-
going isolated CABG. This risk should be adjusted and
then reported to the patient.10 The calculated risk for a
patient can be adjusted using the following formula:
Adjusted risk ¼ Surgeon’s or unit’s observed mortality
Surgeon’s or unit’s predicted mortality
3Patient’s predicted logistic risk
This formula for individual patient’s risk prediction is
appropriate if the unit (hospital) or the respective surgeon
has performed a large number of procedures.10 However,
for a unit with a smaller number of patients, the
calculated logistic risk can be adjusted by the overall
mortality ratio.gery c November 2014
FIGURE E1. Bootstrap calibration of the AusSCORE II model.
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FIGURE E2. Validation of AusSCORE II for the 2012 data. ROC, Receiver operating characteristics.
FIGURE E3. Online calculator for preoperative risk of 30-day mortality
after coronary artery bypass grafting. NYHA, New York Heart Association;
GFR, glomerular filtration rate; EFE, ejection fraction estimated.
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